Mucoepidermoid carcinoma epidemiology and demographics: Difference between revisions
(Mahshid) |
Badria Munir (talk | contribs) No edit summary |
||
Line 7: | Line 7: | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
===Incidence=== | |||
* The overall adjusted incidence rate of mucoepidermoid carcinoma is approximately 2.5 to 3.0 cases per 100,000 individuals a year. | |||
===Prevalence=== | ===Prevalence=== | ||
Line 13: | Line 16: | ||
* Mucoepidermoid carcinoma represents less than 5% of malignancies in the [[Head and neck anatomy|head and neck region]], among the adult population. | * Mucoepidermoid carcinoma represents less than 5% of malignancies in the [[Head and neck anatomy|head and neck region]], among the adult population. | ||
* Mucoepidermoid carcinoma represents about 16% of all salivary gland tumors among the pediatric population. | * Mucoepidermoid carcinoma represents about 16% of all salivary gland tumors among the pediatric population. | ||
===Age=== | ===Age=== | ||
* The | * The median age at diagnosis is between 20 to 60 years.<ref name="raki">Eneroth, C.-M. (1971), Salivary gland tumors in the parotid gland, submandibular gland, and the palate region. Cancer, 27: 1415–1418. doi: 10.1002/1097-0142(197106)27:6<1415::AID-CNCR2820270622>3.0.CO;2-X</ref> | ||
===Gender=== | ===Gender=== | ||
* | * Females are slightly more affected with mucoepidermoid carcinoma than males.<ref name="pmid25085946">{{cite journal |vauthors=Devaraju R, Gantala R, Aitha H, Gotoor SG |title=Mucoepidermoid carcinoma |journal=BMJ Case Rep |volume=2014 |issue= |pages=bcr–2013–202776 |date=August 2014 |pmid=25085946 |pmc=4127757 |doi=10.1136/bcr-2013-202776 |url=}}</ref> | ||
* The male to female ratio is approximately 3:2.<ref name="pmid26813873">{{cite journal |vauthors=Maloth AK, Nandan SR, Kulkarni PG, Dorankula SP, Muddana K |title=Mucoepidermoid Carcinoma of Floor of the Mouth - A Rarity |journal=J Clin Diagn Res |volume=9 |issue=12 |pages=ZD03–4 |date=December 2015 |pmid=26813873 |doi=10.7860/JCDR/2015/15595.6912 |url=}}</ref> | |||
*In mucoepidermoid carcinoma, males are more commonly affected by the aggressive tumor form than females. | *In mucoepidermoid carcinoma, males are more commonly affected by the aggressive tumor form than females. | ||
Revision as of 17:04, 9 January 2019
Mucoepidermoid carcinoma Microchapters |
Differentiating Mucoepidermoid Carcinoma from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Mucoepidermoid carcinoma epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Mucoepidermoid carcinoma epidemiology and demographics |
FDA on Mucoepidermoid carcinoma epidemiology and demographics |
CDC on Mucoepidermoid carcinoma epidemiology and demographics |
Mucoepidermoid carcinoma epidemiology and demographics in the news |
Blogs on Mucoepidermoid carcinoma epidemiology and demographics |
Risk calculators and risk factors for Mucoepidermoid carcinoma epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2]
Overview
Mucoepidermoid carcinoma is the most common malignant salivary gland tumor among general population. The incidence of mucoepidermoid carcinoma is approximately 2.5 to 3.0 cases per 100,000 individuals a year.[1] The incidence of mucoepidermoid carcinoma increases with age. The median age at diagnosis is between 20 to 50 years.[2] Males are slightly more affected with mucoepidermoid carcinoma than females. There is no racial predilection for mucoepidermoid carcinoma.[3]
Epidemiology and Demographics
Incidence
- The overall adjusted incidence rate of mucoepidermoid carcinoma is approximately 2.5 to 3.0 cases per 100,000 individuals a year.
Prevalence
- Mucoepidermoid carcinoma is the most common malignant salivary gland tumor among the general population.[2]
- Mucoepidermoid carcinoma is considered an uncommon tumor among adults.
- Mucoepidermoid carcinoma represents less than 5% of malignancies in the head and neck region, among the adult population.
- Mucoepidermoid carcinoma represents about 16% of all salivary gland tumors among the pediatric population.
Age
- The median age at diagnosis is between 20 to 60 years.[2]
Gender
- Females are slightly more affected with mucoepidermoid carcinoma than males.[4]
- The male to female ratio is approximately 3:2.[5]
- In mucoepidermoid carcinoma, males are more commonly affected by the aggressive tumor form than females.
Race
- There is no racial predilection for mucoepidermoid carcinoma.[2]
References
- ↑ Mucoepidermoid carcinoma. Radiopedia. Dr Frank Gailliard. http://radiopaedia.org/articles/mucoepidermoid-carcinoma-of-salivary-glands Accessed on February 17, 2016
- ↑ 2.0 2.1 2.2 2.3 Eneroth, C.-M. (1971), Salivary gland tumors in the parotid gland, submandibular gland, and the palate region. Cancer, 27: 1415–1418. doi: 10.1002/1097-0142(197106)27:6<1415::AID-CNCR2820270622>3.0.CO;2-X
- ↑ Evans HL (1984). "Mucoepidermoid carcinoma of salivary glands: a study of 69 cases with special attention to histologic grading". Am. J. Clin. Pathol. 81 (6): 696–701. PMID 6731349.
- ↑ Devaraju R, Gantala R, Aitha H, Gotoor SG (August 2014). "Mucoepidermoid carcinoma". BMJ Case Rep. 2014: bcr–2013–202776. doi:10.1136/bcr-2013-202776. PMC 4127757. PMID 25085946.
- ↑ Maloth AK, Nandan SR, Kulkarni PG, Dorankula SP, Muddana K (December 2015). "Mucoepidermoid Carcinoma of Floor of the Mouth - A Rarity". J Clin Diagn Res. 9 (12): ZD03–4. doi:10.7860/JCDR/2015/15595.6912. PMID 26813873.